Metropolitan Life Insurance Company (MetLife)’s Hims & Hers Health HIMS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,575
Closed -$102K 938
2024
Q1
$102K Sell
6,575
-1,258
-16% -$14.2K ﹤0.01% 1037
2023
Q4
$69.7K Hold
7,833
﹤0.01% 1270
2023
Q3
$49.3K Buy
7,833
+1,082
+16% +$8.05K ﹤0.01% 1415
2023
Q2
$63.5K Hold
6,751
﹤0.01% 1285
2023
Q1
$67K Sell
6,751
-1,031
-13% -$9.04K ﹤0.01% 1223
2022
Q4
$49.9K Hold
7,782
﹤0.01% 1476
2022
Q3
$43.4K Hold
7,782
﹤0.01% 1557
2022
Q2
$35.3K Buy
+7,782
New +$33.2K ﹤0.01% 1716

Other funds holding HIMS

Metropolitan Life Insurance Company (MetLife)'s HIMS Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Hims & Hers Health (HIMS) in Q2 2024, closing a stake of 6,575 shares — an estimated $102K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in HIMS in Q2 2022 and held it in 8 quarters. The position peaked at $102K in Q1 2024. 297 funds tracked by Wall St. Rank hold HIMS as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Hims & Hers Health position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 6,575 Hims & Hers Health shares in Q2 2024, an estimated $102K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Hims & Hers Health in Q2 2022 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Hims & Hers Health position peaked at $102K in Q1 2024.
  • 297 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.